Screener / SEC EDGAR /CIK 0001611647 /10-K filed Feb 23, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Consumer staples · Packaged Foods

Freshpet, Inc. FRPT

Compare with peers Embed
Earnings releases

Latest results release: Nov 4, 2026

8-K item 2.02, exhibit 99

What FRPT's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 4, 2026 · EX-99.1

Freshpet, Inc. Reports Third Quarter 2026 Financial Results

Open on SEC

Raises and Narrows 2026 Outlook Bedminster, N.J. – November 4, 2026 – Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its third quarter and nine months ended September 30, 2026.

Third Quarter 2026 Financial Highlights Compared to Prior Year Period • Net sales of $317.8 million, an increase of 10.0%.

• Net income of $29.7 million, compared to the prior year period net income of $101.7 million, which included a discrete $77.9 million tax benefit as a result of sustained profitability.

• Adjusted EBITDA of $64.5 million, or 20.3% as a percentage of net sales, compared to the prior year period of $54.6 million, or 18.9% as a percentage of net sales. 1 “Our third quarter results demonstrate the strength and durability of the Freshpet business model. In a challenging consumer and intense competitive environment, we delivered double-digit net sales growth, expanded margins and achieved our strongest Adjusted Gross Margin in more than seven years, while continuing to grow market share,” commented Billy Cyr, Freshpet’s Chief Executive Officer. “We are executing well against the priorities within our control and strengthening the competitive advantages that differentiate Freshpet, including the quality of our products, our manufacturing scale and expertise, our expanding omnichannel presence and our growing franchise of highly loyal pet parents. We believe these advantages provide a strong foundation to deliver sustainable, profitable growth, capture a meaningful share of the long-term opportunity in fresh pet food and fulfill our mission to help pets live longer, happier and healthier lives with the people who love them.”

Net sales increased 10.0% to $317.8 million for the third quarter of 2026, compared to $288.8 million in the prior year period. The increase in net sales was primarily driven by volume gains of 10.0%.

Gross profit was $141.3 million, or 44.5% as a percentage of net sales, for the third quarter of 2026, compared to $114.2 million, or 39.5% as a percentage of net sales, in the prior year period. Gross profit as a percentage of net sales increased primarily due to improved leverage on plant expenses, reduced quality costs and lower input costs. For the third quarter of 2026, Adjusted Gross Profit was $158.8 million, or 50.0% as a percentage of net sales, compared to $132.8 million, or 46.0% as a percentage of net sales, in the prior year period. 1

Selling, general and administrative expenses (“SG&A”) were $106.2 million, or 33.4% as a percentage of net sales, for the third quarter of 2026, compared to $89.3 million, or 30.9% as a percentage of net sales, in the prior year period. SG&A as a percentage of net sales increased primarily due to increased logistics costs and variable compensation accrual, partially offset by decreased media spend as a percentage of net sales. Adjusted SG&A for the third quarter of 2026 was $94.2 million, or 29.6% as a percentage of net sales, compared to $78.2 million, or 27.1% as a percentage of net sales, in the prior year period. 1

1 Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Measures" for how the Company defines these measures and the financial tables that accompany this release for reconciliations of these measures to the closest comparable GAAP measures. 1 Net income was $29.7 million for the third quarter of 2026 compared to $101.7 million in the prior year period. The decrease in net income was due to the $77.9 million deferred income tax benefit recognized in the prior year period as a result of the release of the majority of the valuation allowance, compared to income tax expense in the current year period, and increases in SG&A, partially offset by contributions from higher sales.

Adjusted EBITDA was $64.5 million for the third quarter of 2026 compared to $54.6 million in the prior year period. The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A.

Net sales increased 12.8% to $921.1 million for the first nine months of 2026, compared to $816.8 million in the prior year period. The increase in net sales was primarily driven by volume gains of 13.3%, partially offset by unfavorable price/mix of 0.5%.

Gross profit was $390.7 million, or 42.4% as a percentage of net sales, for the first nine months of 2026, compared to $326.2 million, or 39.9% as a percentage of net sales, in the prior year period. Gross profit as a percentage of net sales increased primarily due to improved leverage on plant expenses and lower input costs. For the first nine months of 2026, Adjusted Gross Profit was $446.8 million, or 48.5% as a percentage of net sales, compared to $377.1 million, or 46.2% as a percentage of net sales, in the prior year period. 1

SG&A were $329.5 million, or 35.8% as a percentage of net sales, for the first nine months of 2026, compared to $295.0 million, or 36.1% as a percentage of net sales, in the prior year period. SG&A as a percentage of net sales decreased primarily due to a decrease in non-recurring charges compared to 2025, partially offset by increased logistics costs and variable compensation accrual. Adjusted SG&A for the first nine months of 2026 was $291.9 million, or 31.7% as a percentage of net sales, compared to $242.5 million, or 29.7% as a percentage of net sales, in the prior year period.

Net income was $97.7 million for the first nine months of 2026 compared to $105.3 million in the prior year period. The decrease in net income was due to the $77.9 million deferred income tax benefit recognized in the prior year period, compared to income tax expense in the current year period, and increased logistics costs and variable compensation accrual, partially offset by the $66.6 million gain on equity investment, contributions from higher sales, and decreased non-recurring SG&A charges.

Adjusted EBITDA was $154.6 million for the first nine months of 2026 compared to $134.5 million in the prior year period. The increase in Adjusted EBITDA was a result of increased Adjusted Gross Profit, partially offset by higher Adjusted SG&A.

As of September 30, 2026, the Company had cash and cash equivalents of $345.9 million with $399.0 million of debt outstanding, net of $3.5 million of unamortized debt issuance costs. Cash and cash equivalents increased $67.9 million compared to $278.0 million as of December 31, 2025, primarily as a result of the $100.0 million of cash proceeds received from the sale of our equity investment and $65.3 million of Free Cash Flow, partially offset by $102.3 million of share repurchases pursuant to the previously announced share repurchase program. For the nine months ended September 30, 2026, cash from operations was $145.5 million, an increase of $40.1 million compared to the prior year period.

For full year 2026, the Company is updating its guidance and now expects the following:

• Net sales growth in the range of 12% to 13%, compared to growth of 10% to 12% in the previous guidance;

• Adjusted EBITDA in the range of $215 million to $220 million, compared to $210 million to $220 million in the previous guidance; and

• Positive Free Cash Flow with capital expenditures between $125 to $150 million, compared to ~$150 million in the previous guidance.

The Company is reiterating its long-term guidance. For full year 2027, the Company expects:

• Adjusted EBITDA margin in the range of 20% to 22%, unchanged. 2 The Company does not provide guidance for net income, the U.S. GAAP measure most directly comparable to Adjusted EBITDA, and similarly cannot provide a reconciliation between its forecasted Adjusted EBITDA and net income metrics without unreasonable effort due to the unavailability of reliable estimates for certain components of net income and the respective reconciliations, including the timing of and amount of costs of goods sold and selling, general and administrative expenses. These items are not within the Company's control and may vary greatly between periods and could significantly impact future results.

As previously announced, today, November 4, 2026, the Company will host a conference call beginning at 8:00 a.m. Eastern Time with members of its leadership team. The conference call webcast will be available live over the Internet through the "Investors" section of the Company's website at www.freshpet.com. To participate on the live call, listeners in North America may dial (833) 862-0560 and international listeners may dial (412) 634-6361; the passcode is 10212310.

Freshpet's mission is to help dogs and cats live longer, happier, healthier lives with the people who love them. Developed by on-staff Veterinary Nutritionists, Veterinarians and Food Scientists, recipes are made from whole ingredients, like fresh meats, vegetables and fruits, and are cooked in small batches at lower temperatures to preserve their natural goodness and made at our Freshpet Kitchens. Freshpet foods and treats are kept refrigerated until they arrive at Freshpet Fridges in local markets or delivered directly to consumers.

Freshpet is available in select grocery, mass, digital, pet specialty, and club retailers across the United States, Canada and Europe, as well as online in the U.S. From the care they take to source their ingredients and make their food, to the moment it reaches your home, Freshpet's commitment to integrity, transparency and social responsibility is a point of pride.

Certain statements in this press release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on our current expectations and assumptions. These include statements regarding our belief in executing against our priorities, full year 2026 guidance and 2027 financial targets. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking statements including, but not limited to, those identified in connection with such statements, the implementation of our new technologies in the time frame, at the rate, at the cost, or with anticipated efficiencies and impact on product quality we expect, economic uncertainty, changes in rates of pet acquisition, the launch of competitive products at higher quality or less cost, impact of tariffs, fuel, energy and ingredient pricing, effectiveness of media campaigns, success rate of new chillers, organizational changes, our ability to attract and retain talent and most prominently, the risks discussed under the heading "Risk Factors" in the Company's latest annual report on Form 10-K and in quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release. Freshpet undertakes no obligation to publicly update or revise any forward-looking statement because of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Freshpet uses the following non-GAAP financial measures in its financial communications. These non-GAAP financial measures should be considered as supplements to the U.S. GAAP reported measures, should not be considered replacements for, or superior to, the U.S. GAAP measures and may not be comparable to similarly named measures used by other companies. Such financial measures are not financial measures prepared in accordance with U.S. GAAP. • Adjusted Gross Profit

• Adjusted EBITDA 3 • Adjusted EBITDA as a percentage of net sales (Adjusted EBITDA Margin)

• Free Cash Flow Adjusted Gross Profit: Freshpet defines Adjusted Gross Profit as gross profit before depreciation expense, non-cash share-based compensation and loss on disposal of manufacturing equipment.

Adjusted SG&A Expenses: Freshpet defines Adjusted SG&A as SG&A expenses before depreciation and amortization expense, non-cash share-based compensation, loss on disposal of equipment, distributor transition costs, legal obligation and international business charges.

EBITDA and Adjusted EBITDA: EBITDA represents net income plus depreciation and amortization expense, interest expense net of interest income and income tax expense (benefit), and Adjusted EBITDA represents EBITDA less gain on equity investment, plus non-cash share-based compensation expense, loss on disposal of property, plant and equipment, distributor transition costs, legal obligation, and international business charges.

Free Cash Flow: Freshpet defines Free Cash Flow as net cash flows provided by operating activities less capital expenditures.

Management believes that the non-GAAP financial measures are meaningful to investors because they provide a view of the Company with respect to ongoing operating results. The non-GAAP financial measures are shown as supplemental disclosures in this release because they are widely used by the investment community for analysis and comparative evaluation. They also provide additional metrics to evaluate the Company’s operations and, when considered with both the Company’s GAAP results and the reconciliation to their most directly comparable U.S. GAAP measures, provide a more complete understanding of the Company’s business than could be obtained absent this disclosure. The non-GAAP measures are not and should not be considered an alternative to the most directly comparable U.S. GAAP measures or any other figure calculated in accordance with U.S. GAAP, or as an indicator of operating performance. The Company’s calculation of the non-GAAP financial measures may differ from methods used by other companies. Management believes that the non-GAAP measures are important to an understanding of the Company's overall operating results in the periods presented. The non-GAAP financial measures are not recognized in accordance with U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of performance.

September 30, December 31, 2026 2025 ────────────────────────────────────────────────────────────────────────────── ASSETS CURRENT ASSETS: Cash and cash equivalents $ 345,860 $ 277,975 Accounts receivable, net of allowance 68,561 63,762 for doubtful accounts Inventories, net 95,151 76,766 Prepaid expenses 9,875 9,807 Other current assets 7,473 7,404 Total Current Assets 526,920 435,714 Property, plant and equipment, net 1,141,357 1,138,671 Operating lease right of use assets 63,937 66,424 Long term investment in equity — 33,446 securities Deferred tax assets, net 43,082 68,893 Other assets 37,553 34,627 Total Assets $ 1,812,849 $ 1,777,775 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $ 37,366 $ 42,429 Accrued expenses 51,002 31,610 Current operating lease liabilities 2,032 2,241 Current finance lease liabilities 2,449 2,315 Total Current Liabilities $ 92,849 $ 78,595 Convertible senior notes 399,007 397,330 Long term operating lease liabilities 63,619 65,023 Long term finance lease liabilities 26,090 28,075 Deferred tax liabilities, net 158 93 Total Liabilities $ 581,723 $ 569,116 Commitments and contingencies — — STOCKHOLDERS' EQUITY: Common stock — voting, $0.001 par value, 200,000 shares authorized, 50,188 issued 50 49 and 48,329 outstanding on September 30, 2026, and 48,985 issued and 48,970 outstanding on December 31, 2025 Additional paid-in capital 1,379,549 1,351,201 Accumulated deficit -44,961 -142,669 Accumulated other comprehensive (loss) -741 334 income Treasury stock, at cost, inclusive of excise tax and broker fees — 1,859 -102,771 -256 shares on September 30, 2026 and 14 shares on December 31, 2025 Total Stockholders' Equity 1,231,126 1,208,659 Total Liabilities and Stockholders' $ 1,812,849 $ 1,777,775 Equity

For the Nine Months Ended CASH FLOWS FROM September 30, OPERATING ACTIVITIES: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 97,708 $ 105,322 Adjustments to reconcile net income to net cash flows provided by operating activities: Provision for loss on accounts 14 12,130 receivable Loss on disposal of property, plant and 664 1,355 equipment Share-based 21,402 20,256 compensation Depreciation and 73,745 66,798 amortization Amortization of deferred financing 1,677 1,618 costs Change in operating lease right of use 2,487 1,529 asset Deferred income taxes 25,881 -77,919 Gain on equity -66,552 — investment Changes in operating assets and liabilities: Accounts receivable -4,791 -7,410 Inventories -17,671 9,825 Prepaid expenses and other current -688 -3,992 assets Other assets -5,218 80 Accounts payable -1,101 -7,097 Accrued expenses 19,571 -15,874 Operating lease -1,612 -1,166 liability Net cash flows provided by operating 145,516 105,455 activities CASH FLOWS FROM INVESTING ACTIVITIES: Proceeds from sale of 99,998 — equity investment Acquisitions of property, plant and equipment, software -80,259 -95,134 and deposits on equipment Net cash flows provided by (used in) 19,739 -95,134 investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Purchase of treasury stock, inclusive of -102,304 — broker fees Proceeds from exercise of options to 11,736 264 purchase common stock Tax withholdings related to net shares -4,663 -3,054 settlements of restricted stock units Principal payments under finance lease -2,139 -1,573 obligations Net cash flows used in financing -97,370 -4,363 activities NET CHANGE IN CASH AND 67,885 5,958 CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING 277,975 268,633 OF YEAR CASH AND CASH EQUIVALENTS, END OF $ 345,860 $ 274,591 PERIOD

(a) Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.

(b) Represents a non-recurring loss as a result of an accounts receivable write- off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel. (c) Represents the net settlement charges for all claims related to the litigation with Phillips.

(d) Represents termination costs due to a business change in our international go-to-market strategy. 9

(a) Includes true-ups to share-based compensation expense. We have certain outstanding share-based awards with performance-based vesting conditions that require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA and/or Net Sales targets as a condition of vesting. At each reporting period, we reassess the probability of achieving the performance criteria and the performance period required to meet those targets. When the probability of achieving such performance conditions changes, the compensation cost previously recorded is adjusted as needed. When such performance conditions are deemed to be improbable of achievement, the compensation cost previously recorded is reversed.

(b) Represents a non-recurring loss as a result of an accounts receivable write- off in connection with the liquidation of one of our pet specialty distributors. Concurrent with its liquidation, we transitioned to a new distribution partner, who is a leading pet specialty distributor and who we anticipate will facilitate sales to pet specialty stores. Thus, despite the transitory impact during the first quarter of 2025, our ability to continue to generate sales is consistent with what we would expect to generate within the pet specialty channel. (c) Represents the net settlement charges for all claims related to the litigation with Phillips. (d) Represents termination costs due to a business change in our international go-to-market strategy. 10

RECONCILIATION BETWEEN NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES AND FREE CASH FLOW

2 Capital expenditures is equivalent to the amount included in "Acquisitions of property, plant and equipment, software and deposits on equipment" on our Consolidated Statements of Cash Flows for the reported period. 11

Full text with the tables
                                                                                
  Exhibit 99.1                                                                  
                                                                                
                                                                                
          Freshpet, Inc. Reports Third Quarter 2026 Financial Results           
                                                                                
                         Delivers 10% Net Sales Growth                          
                                                                                
         Achieves Gross Margin of 45% and Adjusted Gross Margin of 50%          
                                                                                
                        Raises and Narrows 2026 Outlook                         
Bedminster, N.J. – November 4, 2026 – Freshpet, Inc. (“Freshpet” or the
“Company”) (Nasdaq: FRPT) today reported financial results for its third quarter
and nine months ended September 30, 2026.

Third Quarter 2026 Financial Highlights Compared to Prior Year Period
• Net sales of $317.8 million, an increase of 10.0%.

• Gross margin of 44.5%, compared to the prior year period of 39.5%.

• Adjusted Gross Margin of 50.0%, compared to the prior year period of 46.0%. 1

• Net income of $29.7 million, compared to the prior year period net income of
$101.7 million, which included a discrete $77.9 million tax benefit as a result
of sustained profitability.

• Adjusted EBITDA of $64.5 million, or 20.3% as a percentage of net sales,
compared to the prior year period of $54.6 million, or 18.9% as a percentage of
net sales. 1
“Our third quarter results demonstrate the strength and durability of the
Freshpet business model. In a challenging consumer and intense competitive
environment, we delivered double-digit net sales growth, expanded margins and
achieved our strongest Adjusted Gross Margin in more than seven years, while
continuing to grow market share,” commented Billy Cyr, Freshpet’s Chief
Executive Officer. “We are executing well against the priorities within our
control and strengthening the competitive advantages that differentiate
Freshpet, including the quality of our products, our manufacturing scale and
expertise, our expanding omnichannel presence and our growing franchise of
highly loyal pet parents. We believe these advantages provide a strong
foundation to deliver sustainable, profitable growth, capture a meaningful share
of the long-term opportunity in fresh pet food and fulfill our mission to help
pets live longer, happier and healthier lives with the people who love them.”
                                                                                
  Third Quarter 2026                                                            
                                                                                
Net sales increased 10.0% to $317.8 million for the third quarter of 2026,
compared to $288.8 million in the prior year period. The increase in net sales
was primarily driven by volume gains of 10.0%.

Gross profit was $141.3 million, or 44.5% as a percentage of net sales, for the
third quarter of 2026, compared to $114.2 million, or 39.5% as a percentage of
net sales, in the prior year period. Gross profit as a percentage of net sales
increased primarily due to improved leverage on plant expenses, reduced quality
costs and lower input costs. For the third quarter of 2026, Adjusted Gross
Profit was $158.8 million, or 50.0% as a percentage of net sales, compared to
$132.8 million, or 46.0% as a percentage of net sales, in the prior year period.
1

Selling, general and administrative expenses (“SG&A”) were $106.2 million, or
33.4% as a percentage of net sales, for the third quarter of 2026, compared to
$89.3 million, or 30.9% as a percentage of net sales, in the prior year period.
SG&A as a percentage of net sales increased primarily due to increased logistics
costs and variable compensation accrual, partially offset by decreased media
spend as a percentage of net sales. Adjusted SG&A for the third quarter of 2026
was $94.2 million, or 29.6% as a percentage of net sales, compared to $78.2
million, or 27.1% as a percentage of net sales, in the prior year period. 1

1 Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA
and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Measures" for
how the Company defines these measures and the financial tables that accompany
this release for reconciliations of these measures to the closest comparable
GAAP measures.
                                       1                                        
Net income was $29.7 million for the third quarter of 2026 compared to $101.7
million in the prior year period. The decrease in net income was due to the
$77.9 million deferred income tax benefit recognized in the prior year period as
a result of the release of the majority of the valuation allowance, compared to
income tax expense in the current year period, and increases in SG&A, partially
offset by contributions from higher sales.

Adjusted EBITDA was $64.5 million for the third quarter of 2026 compared to
$54.6 million in the prior year period. The increase in Adjusted EBITDA was a
result of increased Adjusted Gross Profit, partially offset by higher Adjusted
SG&A.
                                                                                
  First Nine Months of 2026                                                     
                                                                                
Net sales increased 12.8% to $921.1 million for the first nine months of 2026,
compared to $816.8 million in the prior year period. The increase in net sales
was primarily driven by volume gains of 13.3%, partially offset by unfavorable
price/mix of 0.5%.

Gross profit was $390.7 million, or 42.4% as a percentage of net sales, for the
first nine months of 2026, compared to $326.2 million, or 39.9% as a percentage
of net sales, in the prior year period. Gross profit as a percentage of net
sales increased primarily due to improved leverage on plant expenses and lower
input costs. For the first nine months of 2026, Adjusted Gross Profit was $446.8
million, or 48.5% as a percentage of net sales, compared to $377.1 million, or
46.2% as a percentage of net sales, in the prior year period. 1

SG&A were $329.5 million, or 35.8% as a percentage of net sales, for the first
nine months of 2026, compared to $295.0 million, or 36.1% as a percentage of net
sales, in the prior year period. SG&A as a percentage of net sales decreased
primarily due to a decrease in non-recurring charges compared to 2025, partially
offset by increased logistics costs and variable compensation accrual. Adjusted
SG&A for the first nine months of 2026 was $291.9 million, or 31.7% as a
percentage of net sales, compared to $242.5 million, or 29.7% as a percentage of
net sales, in the prior year period.

Net income was $97.7 million for the first nine months of 2026 compared to
$105.3 million in the prior year period. The decrease in net income was due to
the $77.9 million deferred income tax benefit recognized in the prior year
period, compared to income tax expense in the current year period, and increased
logistics costs and variable compensation accrual, partially offset by the $66.6
million gain on equity investment, contributions from higher sales, and
decreased non-recurring SG&A charges.

Adjusted EBITDA was $154.6 million for the first nine months of 2026 compared to
$134.5 million in the prior year period. The increase in Adjusted EBITDA was a
result of increased Adjusted Gross Profit, partially offset by higher Adjusted
SG&A.
                                                                                
  Balance Sheet                                                                 
                                                                                
As of September 30, 2026, the Company had cash and cash equivalents of $345.9
million with $399.0 million of debt outstanding, net of $3.5 million of
unamortized debt issuance costs. Cash and cash equivalents increased $67.9
million compared to $278.0 million as of December 31, 2025, primarily as a
result of the $100.0 million of cash proceeds received from the sale of our
equity investment and $65.3 million of Free Cash Flow, partially offset by
$102.3 million of share repurchases pursuant to the previously announced share
repurchase program. For the nine months ended September 30, 2026, cash from
operations was $145.5 million, an increase of $40.1 million compared to the
prior year period.
                                                                                
  Outlook                                                                       
                                                                                
For full year 2026, the Company is updating its guidance and now expects the
following:

• Net sales growth in the range of 12% to 13%, compared to growth of 10% to 12%
in the previous guidance;

• Adjusted EBITDA in the range of $215 million to $220 million, compared to $210
million to $220 million in the previous guidance; and

• Positive Free Cash Flow with capital expenditures between $125 to $150
million, compared to ~$150 million in the previous guidance.

The Company is reiterating its long-term guidance. For full year 2027, the
Company expects:

• Net sales well in excess of the category growth rate, unchanged;

• Adjusted Gross Margin of at least 49%, unchanged; and

• Adjusted EBITDA margin in the range of 20% to 22%, unchanged.
                                       2                                        
The Company does not provide guidance for net income, the U.S. GAAP measure most
directly comparable to Adjusted EBITDA, and similarly cannot provide a
reconciliation between its forecasted Adjusted EBITDA and net income metrics
without unreasonable effort due to the unavailability of reliable estimates for
certain components of net income and the respective reconciliations, including
the timing of and amount of costs of goods sold and selling, general and
administrative expenses. These items are not within the Company's control and
may vary greatly between periods and could significantly impact future results.

Conference Call & Earnings Presentation Webcast Information

As previously announced, today, November 4, 2026, the Company will host a
conference call beginning at 8:00 a.m. Eastern Time with members of its
leadership team. The conference call webcast will be available live over the
Internet through the "Investors" section of the Company's website at
www.freshpet.com. To participate on the live call, listeners in North America
may dial (833) 862-0560 and international listeners may dial (412) 634-6361; the
passcode is 10212310.
                                                                                
  About Freshpet                                                                
                                                                                
Freshpet's mission is to help dogs and cats live longer, happier, healthier
lives with the people who love them. Developed by on-staff Veterinary
Nutritionists, Veterinarians and Food Scientists, recipes are made from whole
ingredients, like fresh meats, vegetables and fruits, and are cooked in small
batches at lower temperatures to preserve their natural goodness and made at our
Freshpet Kitchens. Freshpet foods and treats are kept refrigerated until they
arrive at Freshpet Fridges in local markets or delivered directly to consumers.

Freshpet is available in select grocery, mass, digital, pet specialty, and club
retailers across the United States, Canada and Europe, as well as online in the
U.S. From the care they take to source their ingredients and make their food, to
the moment it reaches your home, Freshpet's commitment to integrity,
transparency and social responsibility is a point of pride.
                                                                                
  Forward Looking Statements                                                    
                                                                                
Certain statements in this press release constitute “forward-looking” statements
within the meaning of the Private Securities Litigation Reform Act of 1995 and
are based on our current expectations and assumptions. These include statements
regarding our belief in executing against our priorities, full year 2026
guidance and 2027 financial targets. Such statements are subject to risks and
uncertainties that could cause actual results to differ materially from those
discussed in the forward-looking statements including, but not limited to, those
identified in connection with such statements, the implementation of our new
technologies in the time frame, at the rate, at the cost, or with anticipated
efficiencies and impact on product quality we expect, economic uncertainty,
changes in rates of pet acquisition, the launch of competitive products at
higher quality or less cost, impact of tariffs, fuel, energy and ingredient
pricing, effectiveness of media campaigns, success rate of new chillers,
organizational changes, our ability to attract and retain talent and most
prominently, the risks discussed under the heading "Risk Factors" in the
Company's latest annual report on Form 10-K and in quarterly reports on Form
10-Q filed with the Securities and Exchange Commission. Such forward-looking
statements are made only as of the date of this release. Freshpet undertakes no
obligation to publicly update or revise any forward-looking statement because of
new information, future events or otherwise, except as otherwise required by
law. If we do update one or more forward-looking statements, no inference should
be made that we will make additional updates with respect to those or other
forward-looking statements.
                                                                                
   Non-GAAP Financial Measures                                                  
                                                                                
Freshpet uses the following non-GAAP financial measures in its financial
communications. These non-GAAP financial measures should be considered as
supplements to the U.S. GAAP reported measures, should not be considered
replacements for, or superior to, the U.S. GAAP measures and may not be
comparable to similarly named measures used by other companies. Such financial
measures are not financial measures prepared in accordance with U.S. GAAP.
• Adjusted Gross Profit

• Adjusted Gross Profit as a percentage of net sales (Adjusted Gross Margin)

• Adjusted SG&A Expenses

• Adjusted SG&A Expenses as a percentage of net sales

• EBITDA

• Adjusted EBITDA
                                       3                                        
• Adjusted EBITDA as a percentage of net sales (Adjusted EBITDA Margin)

• Free Cash Flow
Adjusted Gross Profit: Freshpet defines Adjusted Gross Profit as gross profit
before depreciation expense, non-cash share-based compensation and loss on
disposal of manufacturing equipment.

Adjusted SG&A Expenses: Freshpet defines Adjusted SG&A as SG&A expenses before
depreciation and amortization expense, non-cash share-based compensation, loss
on disposal of equipment, distributor transition costs, legal obligation and
international business charges.

EBITDA and Adjusted EBITDA: EBITDA represents net income plus depreciation and
amortization expense, interest expense net of interest income and income tax
expense (benefit), and Adjusted EBITDA represents EBITDA less gain on equity
investment, plus non-cash share-based compensation expense, loss on disposal of
property, plant and equipment, distributor transition costs, legal obligation,
and international business charges.

Free Cash Flow: Freshpet defines Free Cash Flow as net cash flows provided by
operating activities less capital expenditures.

Management believes that the non-GAAP financial measures are meaningful to
investors because they provide a view of the Company with respect to ongoing
operating results. The non-GAAP financial measures are shown as supplemental
disclosures in this release because they are widely used by the investment
community for analysis and comparative evaluation. They also provide additional
metrics to evaluate the Company’s operations and, when considered with both the
Company’s GAAP results and the reconciliation to their most directly comparable
U.S. GAAP measures, provide a more complete understanding of the Company’s
business than could be obtained absent this disclosure. The non-GAAP measures
are not and should not be considered an alternative to the most directly
comparable U.S. GAAP measures or any other figure calculated in accordance with
U.S. GAAP, or as an indicator of operating performance. The Company’s
calculation of the non-GAAP financial measures may differ from methods used by
other companies. Management believes that the non-GAAP measures are important to
an understanding of the Company's overall operating results in the periods
presented. The non-GAAP financial measures are not recognized in accordance with
U.S. GAAP and should not be viewed as an alternative to U.S. GAAP measures of
performance.

Investor Contact:

Rachel Ulsh

[email protected]

Media Contact:

[email protected]
                                       4                                        
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
                     CONDENSED CONSOLIDATED BALANCE SHEETS                      
                                                                                
                (Unaudited, in thousands, except per share data)                
                                                                                
                                              September 30,       December 31,  
                                                       2026               2025  
 ────────────────────────────────────────────────────────────────────────────── 
  ASSETS                                                                        
  CURRENT ASSETS:                                                               
  Cash and cash equivalents                $        345,860    $       277,975  
  Accounts receivable, net of allowance              68,561             63,762  
  for doubtful accounts                                                         
  Inventories, net                                   95,151             76,766  
  Prepaid expenses                                    9,875              9,807  
  Other current assets                                7,473              7,404  
  Total Current Assets                              526,920            435,714  
  Property, plant and equipment, net              1,141,357          1,138,671  
  Operating lease right of use assets                63,937             66,424  
  Long term investment in equity                          —             33,446  
  securities                                                                    
  Deferred tax assets, net                           43,082             68,893  
  Other assets                                       37,553             34,627  
  Total Assets                             $      1,812,849    $     1,777,775  
  LIABILITIES AND STOCKHOLDERS' EQUITY                                          
  CURRENT LIABILITIES:                                                          
  Accounts payable                         $         37,366    $        42,429  
  Accrued expenses                                   51,002             31,610  
  Current operating lease liabilities                 2,032              2,241  
  Current finance lease liabilities                   2,449              2,315  
  Total Current Liabilities                $         92,849    $        78,595  
  Convertible senior notes                          399,007            397,330  
  Long term operating lease liabilities              63,619             65,023  
  Long term finance lease liabilities                26,090             28,075  
  Deferred tax liabilities, net                         158                 93  
  Total Liabilities                        $        581,723    $       569,116  
  Commitments and contingencies                           —                  —  
  STOCKHOLDERS' EQUITY:                                                         
  Common stock — voting, $0.001 par                                             
  value,                                                                        
  200,000 shares authorized, 50,188                                             
  issued                                                 50                 49  
  and 48,329 outstanding on September                                           
  30,                                                                           
  2026, and 48,985 issued and 48,970                                            
  outstanding on December 31, 2025                                              
  Additional paid-in capital                      1,379,549          1,351,201  
  Accumulated deficit                               -44,961           -142,669  
  Accumulated other comprehensive                                               
  (loss)                                               -741                334  
  income                                                                        
  Treasury stock, at cost, inclusive of                                         
  excise tax and broker fees — 1,859               -102,771               -256  
  shares on September 30, 2026 and 14                                           
  shares on December 31, 2025                                                   
  Total Stockholders' Equity                      1,231,126          1,208,659  
  Total Liabilities and Stockholders'      $      1,812,849    $     1,777,775  
  Equity                                                                        
                                                                                
                                       5                                        
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
      CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME      
                                                                                
                (Unaudited, in thousands, except per share data)                
                                                                                
              For                                  For                          
              the                                  the                          
              Th…                                  Ni…                          
              Mo…                                  Mo…                          
              En…                                  En…                          
              Se…                                  Se…                          
        2026  30,          20…               2026  30,          20…             
 ────────────────────────────────────────────────────────────────────────────── 
  N…    $     31…          $    288…         $     92…          $    816…       
  S…                                                                            
  C…                                                                            
  OF          17…               174…               53…               490…       
  G…                                                                            
  S…                                                                            
  G…          14…               114…               39…               326…       
  P…                                                                            
  S…                                                                            
  G…                                                                            
  A…          10…               89,…               32…               294…       
  A…                                                                            
  E…                                                                            
  I…                                                                            
  F…          35…               24,…               61…               31,…       
  O…                                                                            
  O…                                                                            
  (…                                                                            
  I…                                                                            
  I…                                                                            
  a…                                                                            
  O…          2,…               2,3…               8,…               6,9…       
  I…                                                                            
  n…                                                                            
  I…          -3…               -3,…               -1…               -10…       
  E…                                                                            
  G…                                                                            
  on            —                  —               66…                  —       
  E…                                                                            
  I…                                                                            
  T…                                                                            
  O…          -7…               -1,…               64…               -3,…       
  (…                                                                            
  I…                                                                            
  I…                                                                            
  B…          34…               23,…               12…               27,…       
  I…                                                                            
  T…                                                                            
  I…                                                                            
  T…          4,…               -77…               27…               -77…       
  E…                                                                            
  (…                                                                            
  I…                                                                            
  A…                                                                            
  TO    $     29…          $    101…         $     97…          $    105…       
  C…                                                                            
  S…                                                                            
  O…                                                                            
  C…                                                                            
  (…                                                                            
  I…                                                                            
  C…                                                                            
  in                                                                            
  f…    $     -35          $     -86         $     -1…          $     365       
  c…                                                                            
  t…                                                                            
  T…                                                                            
  O…                                                                            
  C…          -35                -86               -1…                365       
  (…                                                                            
  I…                                                                            
  T…                                                                            
  C…    $     29…          $    101…         $     96…          $    105…       
  I…                                                                            
  N…                                                                            
  I…                                                                            
  P…                                                                            
  S…                                                                            
  A…                                                                            
  TO                                                                            
  C…                                                                            
  S…                                                                            
  -…    $     0.…          $    2.08         $     2.…          $    2.16       
  -…    $     0.…          $    1.86         $     1.…          $    2.00       
  W…                                                                            
  A…                                                                            
  S…                                                                            
  OF                                                                            
  C…                                                                            
  S…                                                                            
  O…                                                                            
  -…               48,…               48…               48,…               48…  
  -…               54,…               55…               55,…               55…  
                                                                                
                                       6                                        
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS                 
                                                                                
                           (Unaudited, in thousands)                            
                                                                                
                            For the Nine Months                                 
                            Ended                                               
  CASH FLOWS FROM           September 30,                                       
  OPERATING ACTIVITIES:     2026                                 2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Net income                $                          97,708    $     105,322  
  Adjustments to                                                                
  reconcile net income                                                          
  to                                                                            
  net cash flows                                                                
  provided by operating                                                         
  activities:                                                                   
  Provision for loss on                                                         
  accounts                                                 14           12,130  
  receivable                                                                    
  Loss on disposal of                                                           
  property, plant and                                     664            1,355  
  equipment                                                                     
  Share-based                                          21,402           20,256  
  compensation                                                                  
  Depreciation and                                     73,745           66,798  
  amortization                                                                  
  Amortization of                                                               
  deferred financing                                    1,677            1,618  
  costs                                                                         
  Change in operating                                                           
  lease right of use                                    2,487            1,529  
  asset                                                                         
  Deferred income taxes                                25,881          -77,919  
  Gain on equity                                      -66,552                —  
  investment                                                                    
  Changes in operating                                                          
  assets and                                                                    
  liabilities:                                                                  
  Accounts receivable                                  -4,791           -7,410  
  Inventories                                         -17,671            9,825  
  Prepaid expenses and                                                          
  other current                                          -688           -3,992  
  assets                                                                        
  Other assets                                         -5,218               80  
  Accounts payable                                     -1,101           -7,097  
  Accrued expenses                                     19,571          -15,874  
  Operating lease                                      -1,612           -1,166  
  liability                                                                     
  Net cash flows                                                                
  provided by operating                               145,516          105,455  
  activities                                                                    
  CASH FLOWS FROM                                                               
  INVESTING ACTIVITIES:                                                         
  Proceeds from sale of                                99,998                —  
  equity investment                                                             
  Acquisitions of                                                               
  property, plant and                                                           
  equipment, software                                 -80,259          -95,134  
  and deposits on                                                               
  equipment                                                                     
  Net cash flows                                                                
  provided by (used in)                                19,739          -95,134  
  investing activities                                                          
  CASH FLOWS FROM                                                               
  FINANCING ACTIVITIES:                                                         
  Purchase of treasury                                                          
  stock, inclusive of                                -102,304                —  
  broker fees                                                                   
  Proceeds from exercise                                                        
  of options to                                        11,736              264  
  purchase common stock                                                         
  Tax withholdings                                                              
  related to net shares                                -4,663           -3,054  
  settlements of                                                                
  restricted stock units                                                        
  Principal payments                                                            
  under finance lease                                  -2,139           -1,573  
  obligations                                                                   
  Net cash flows used in                                                        
  financing                                           -97,370           -4,363  
  activities                                                                    
  NET CHANGE IN CASH AND                               67,885            5,958  
  CASH EQUIVALENTS                                                              
  CASH AND CASH                                                                 
  EQUIVALENTS, BEGINNING                              277,975          268,633  
  OF                                                                            
  YEAR                                                                          
  CASH AND CASH                                                                 
  EQUIVALENTS, END OF       $                         345,860    $     274,591  
  PERIOD                                                                        
                                                                                
                                       7                                        
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
         RECONCILIATION BETWEEN GROSS PROFIT AND ADJUSTED GROSS PROFIT          
                                                                                
                                                                                
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                                Nine                             
          30,                                  Mon…                             
          2026                                 End…                             
          (Dol…                                Sep…                             
          in                                   30,                              
          thou…              2025              2026              2025           
 ────────────────────────────────────────────────────────────────────────────── 
  Gro…    $      141,…       $     114,…       $     390,…       $     326…     
  pro…                                                                          
  Dep…           16,2…             17,1…             51,3…             46,…     
  exp…                                                                          
  Non…                                                                          
  sha…           1,139             1,503             4,608             4,6…     
  com…                                                                          
  Loss                                                                          
  on                                                                            
  dis…             118                32               130              287     
  of                                                                            
  man…                                                                          
  equ…                                                                          
  Adj…                                                                          
  Gro…    $      158,…       $     132,…       $     446,…       $     377…     
  Pro…                                                                          
  Adj…                                                                          
  Gro…                                                                          
  Pro…                                                                          
  as a            50.0  %           46.0  %           48.5  %          46.2  %  
  % of                                                                          
  Net                                                                           
  Sal…                                                                          
                                                                                
                                       8                                        
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
        RECONCILIATION BETWEEN SG&A EXPENSES AND ADJUSTED SG&A EXPENSES         
                                                                                
                                                                                
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                               Nine                              
          30,                                 Mont…                             
          2026                                Ended                             
          (Dol…                               Sept…                             
          in                                  30,                               
          thou…              2025             2026              2025            
 ────────────────────────────────────────────────────────────────────────────── 
  SG&A    $      106,…       $     89,…       $      329…       $     294,…     
  exp…                                                                          
  Dep…                                                                          
  and            6,856             6,5…              20,…             18,6…     
  amo…                                                                          
  exp…                                                                          
  Non…                                                                          
  sha…           4,747             3,7…              16,…             15,6…     
  com…                                                                          
  (a)                                                                           
  Loss                                                                          
  on                                                                            
  dis…             392               94               534               486     
  of                                                                            
  equ…                                                                          
  Dis…                                                                          
  tra…               —                —                 —             10,6…     
  cos…                                                                          
  (b)                                                                           
  Leg…                                                                          
  obl…               —              716                 —             5,703     
  (c)                                                                           
  Int…                                                                          
  bus…               —                —                 —             1,273     
  cha…                                                                          
  (d)                                                                           
  Adj…                                                                          
  SG&A    $      94,1…       $     78,…       $      291…       $     242,…     
  Exp…                                                                          
  Adj…                                                                          
  SG&A                                                                          
  Exp…                                                                          
  as a            29.6  %          27.1  %           31.7  %           29.7  %  
  % of                                                                          
  Net                                                                           
  Sal…                                                                          
                                                                                
(a) Includes true-ups to share-based compensation expense. We have certain
outstanding share-based awards with performance-based vesting conditions that
require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA
and/or Net Sales targets as a condition of vesting. At each reporting period, we
reassess the probability of achieving the performance criteria and the
performance period required to meet those targets. When the probability of
achieving such performance conditions changes, the compensation cost previously
recorded is adjusted as needed. When such performance conditions are deemed to
be improbable of achievement, the compensation cost previously recorded is
reversed.

(b) Represents a non-recurring loss as a result of an accounts receivable write-
off in connection with the liquidation of one of our pet specialty distributors.
Concurrent with its liquidation, we transitioned to a new distribution partner,
who is a leading pet specialty distributor and who we anticipate will facilitate
sales to pet specialty stores. Thus, despite the transitory impact during the
first quarter of 2025, our ability to continue to generate sales is consistent
with what we would expect to generate within the pet specialty channel.
(c) Represents the net settlement charges for all claims related to the
litigation with Phillips.

(d) Represents termination costs due to a business change in our international
go-to-market strategy.
                                       9                                        
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
             RECONCILIATION BETWEEN NET INCOME AND ADJUSTED EBITDA              
                                                                                
                                                                                
          Three                                                                 
          Mont…                                                                 
          Ended                                                                 
          Sept…                               Nine                              
          30,                                 Mont…                             
          2026                                Ended                             
          (Dol…                               Sept…                             
          in                                  30,                               
          thou…              2025             2026              2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Net     $      29,7…       $     101…       $      97,…       $     105,…     
  inc…                                                                          
  Dep…                                                                          
  and            23,0…             23,…              71,…             64,6…     
  amo…                                                                          
  Int…                                                                          
  exp…                                                                          
  net              645             1,1…              1,8…             3,803     
  of                                                                            
  int…                                                                          
  inc…                                                                          
  Inc…                                                                          
  tax            4,711             -77…              27,…             -77,…     
  exp…                                                                          
  (be…                                                                          
  EBI…           58,1…             48,…              199…             95,8…     
  Non…                                                                          
  sha…           5,886             5,2…              21,…             20,2…     
  com…                                                                          
  (a)                                                                           
  Loss                                                                          
  on                                                                            
  dis…                                                                          
  of               510              126               664               773     
  pro…                                                                          
  pla…                                                                          
  and                                                                           
  equ…                                                                          
  Gain                                                                          
  on                 —                —              -66…                 —     
  equ…                                                                          
  inv…                                                                          
  Dis…                                                                          
  tra…               —                —                 —             10,6…     
  cos…                                                                          
  (b)                                                                           
  Leg…                                                                          
  obl…               —              716                 —             5,703     
  (c)                                                                           
  Int…                                                                          
  bus…               —                —                 —             1,273     
  cha…                                                                          
  (d)                                                                           
  Adj…    $      64,5…       $     54,…       $      154…       $     134,…     
  EBI…                                                                          
  Adj…                                                                          
  EBI…                                                                          
  as a            20.3  %          18.9  %           16.8  %           16.5  %  
  % of                                                                          
  Net                                                                           
  Sal…                                                                          
                                                                                
(a) Includes true-ups to share-based compensation expense. We have certain
outstanding share-based awards with performance-based vesting conditions that
require the achievement of certain Adjusted EBITDA margins, Adjusted EBITDA
and/or Net Sales targets as a condition of vesting. At each reporting period, we
reassess the probability of achieving the performance criteria and the
performance period required to meet those targets. When the probability of
achieving such performance conditions changes, the compensation cost previously
recorded is adjusted as needed. When such performance conditions are deemed to
be improbable of achievement, the compensation cost previously recorded is
reversed.

(b) Represents a non-recurring loss as a result of an accounts receivable write-
off in connection with the liquidation of one of our pet specialty distributors.
Concurrent with its liquidation, we transitioned to a new distribution partner,
who is a leading pet specialty distributor and who we anticipate will facilitate
sales to pet specialty stores. Thus, despite the transitory impact during the
first quarter of 2025, our ability to continue to generate sales is consistent
with what we would expect to generate within the pet specialty channel.
(c) Represents the net settlement charges for all claims related to the
litigation with Phillips.
(d) Represents termination costs due to a business change in our international
go-to-market strategy.
                                       10                                       
                                                                                
                        FRESHPET, INC. AND SUBSIDIARIES                         
                                                                                
                                                                                
   RECONCILIATION BETWEEN NET CASH FLOWS PROVIDED BY OPERATING ACTIVITIES AND   
   FREE CASH FLOW                                                               
                                                                                
                                                                                
                         Nine Months Ended                                      
                         September 30,                                          
                         2026                                                   
                         (Dollars in                                            
                         thousands)                           2025              
 ────────────────────────────────────────────────────────────────────────────── 
  Net cash flows                                                                
  provided by            $                      145,516       $     105,455     
  operating                                                                     
  activities                                                                    
  less: capital                                 -80,259             -95,134     
  expenditures2                                                                 
  Free Cash Flow         $                       65,257       $      10,321     
  Free Cash Flow as a                               7.1  %              1.3  %  
  % of Net Sales                                                                
                                                                                
2 Capital expenditures is equivalent to the amount included in "Acquisitions of
property, plant and equipment, software and deposits on equipment" on our
Consolidated Statements of Cash Flows for the reported period.
                                       11                                       

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/FRPT/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.